BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND U2AF1, ENSG00000160201, 7307, Q01081, U2AFBP, U2AF35, RNU2AF1, RN, FP793, DKFZp313J1712 AND Treatment
7 results:

  • 1. IRAK-4 inhibition: emavusertib for the treatment of lymphoid and myeloid malignancies.
    Parrondo RD; Iqbal M; Von Roemeling R; Von Roemeling C; Tun HW
    Front Immunol; 2023; 14():1239082. PubMed ID: 37954584
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Genomics improves risk stratification of adults with T-cell acute lymphoblastic leukemia enrolled in measurable residual disease-oriented trials.
    González-Gil C; Morgades M; Lopes T; Fuster-Tormo F; García-Chica J; Zhao R; Montesinos P; Torrent A; Diaz-Beya M; Coll R; Hermosín L; Mercadal S; González-Campos J; Zamora L; Artola T; Vall-Llovera F; Tormo M; Gil-Cortés C; Barba P; Novo A; Ribera J; Bernal T; De Ugarriza PL; Queipo MP; Martínez-Sánchez P; Giménez A; González-Martínez T; Cladera A; Cervera J; Fernández-Martín R; Ardaiz MÁ; Vidal MJ; Baena Á; López-Bigas N; Bigas A; Maciejewski J; Orfao A; Ribera JM; Genescà E
    Haematologica; 2023 Apr; 108(4):969-980. PubMed ID: 36325893
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Resolution of radiation necrosis with bevacizumab following radiation therapy for primary CNS lymphoma.
    Vaios EJ; Batich KA; Buckley AF; Dunn-Pirio A; Patel MP; Kirkpatrick JP; Goudar R; Peters KB
    Oncotarget; 2022; 13():576-582. PubMed ID: 35359747
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Aberrant RNA splicing and therapeutic opportunities in cancers.
    Yamauchi H; Nishimura K; Yoshimi A
    Cancer Sci; 2022 Feb; 113(2):373-381. PubMed ID: 34812550
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. u2af1 expression is a novel and independent prognostic indicator of childhood T-lineage acute lymphoblastic leukemia.
    Zhang P; Zhang Y; Li X; Ying P; Tang Y
    Int J Lab Hematol; 2021 Aug; 43(4):675-682. PubMed ID: 33314767
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Retrospective Analysis of the Clinical Use and Benefit of Lenalidomide and Thalidomide in Myelofibrosis.
    Castillo-Tokumori F; Talati C; Al Ali N; Sallman D; Yun S; Sweet K; Padron E; Lancet J; Komrokji R; Kuykendall AT
    Clin Lymphoma Myeloma Leuk; 2020 Dec; 20(12):e956-e960. PubMed ID: 32778513
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Genomic characterization of pediatric T-cell acute lymphoblastic leukemia reveals novel recurrent driver mutations.
    Spinella JF; Cassart P; Richer C; Saillour V; Ouimet M; Langlois S; St-Onge P; Sontag T; Healy J; Minden MD; Sinnett D
    Oncotarget; 2016 Oct; 7(40):65485-65503. PubMed ID: 27602765
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.